230 related articles for article (PubMed ID: 18633100)
1. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.
Cabou C; Campistron G; Marsollier N; Leloup C; Cruciani-Guglielmacci C; Pénicaud L; Drucker DJ; Magnan C; Burcelin R
Diabetes; 2008 Oct; 57(10):2577-87. PubMed ID: 18633100
[TBL] [Abstract][Full Text] [Related]
2. Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.
Cabou C; Vachoux C; Campistron G; Drucker DJ; Burcelin R
Diabetes; 2011 Sep; 60(9):2245-56. PubMed ID: 21810595
[TBL] [Abstract][Full Text] [Related]
3. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
[TBL] [Abstract][Full Text] [Related]
4. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Rudd JA
Eur J Pharmacol; 2011 Oct; 668(1-2):340-6. PubMed ID: 21756894
[TBL] [Abstract][Full Text] [Related]
5. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
6. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
Vahl TP; Tauchi M; Durler TS; Elfers EE; Fernandes TM; Bitner RD; Ellis KS; Woods SC; Seeley RJ; Herman JP; D'Alessio DA
Endocrinology; 2007 Oct; 148(10):4965-73. PubMed ID: 17584962
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Doyle ME; Egan JM
Pharmacol Ther; 2007 Mar; 113(3):546-93. PubMed ID: 17306374
[TBL] [Abstract][Full Text] [Related]
10. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
[TBL] [Abstract][Full Text] [Related]
11. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
12. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.
Rieg T; Gerasimova M; Murray F; Masuda T; Tang T; Rose M; Drucker DJ; Vallon V
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F963-71. PubMed ID: 22832924
[TBL] [Abstract][Full Text] [Related]
14. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
15. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.
Griffioen KJ; Wan R; Okun E; Wang X; Lovett-Barr MR; Li Y; Mughal MR; Mendelowitz D; Mattson MP
Cardiovasc Res; 2011 Jan; 89(1):72-8. PubMed ID: 20736238
[TBL] [Abstract][Full Text] [Related]
17. Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
Nakashima K; Shimoda M; Hamamoto S; Tatsumi F; Hirukawa H; Tawaramoto K; Kanda Y; Kaku K
Mol Cell Endocrinol; 2012 Feb; 349(2):281-8. PubMed ID: 22108438
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
20. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]